“The Idea of Being Without It is Frightening”. Uncertainty and Psychological Dependency for Patients Using Immuno‐, Biological, or Precision Therapies: A Qualitative Study
Psycho-Oncology · 2025
DOI: 10.1002/pon.70318 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Psycho-Oncology, 2025. Verfasst von J Lecouturier und 11 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK. Hauptthemen laut MEDLINE: Neoplasms, Precision Medicine, Immunotherapy, Biological Therapy. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Macmillan Cancer Support.
Abstract (Originalsprache)
Background
IBP therapies (immunotherapies, biologics and precision therapies) have had a significant impact on cancer survival. They differ from conventional cancer treatments in that they may be used long term and have less predictable adverse effects. We aimed to explore the psychological impact of IBP therapies from the perspectives of those living with advanced cancer.
Methods
Semi‐structured interviews with 20 women and 11 men with advanced cancer ‐ (lung, colorectal, ovary, (female) breast, renal and malignant melanoma) ‐ about their experiences of IBP therapies. Data were analysed thematically.
Results
We elicited two overarching themes from the data: (1) the psychological impact of a stage IV diagnosis and living with advanced cancer, and (2) uncertainty and dependency associated with IBP therapies. Although some were relieved to have a diagnosis, others responded with shock and disbelief. Day to day, cancer was foremost in the minds of many, and the remainder chose to push these thoughts aside and focus on making the most of life. Living with cancer led to a shift in their sense of self. Uncertainty and dependency throughout the care pathway were centred around treatment effectiveness, heightened by the belief that the therapy was keeping them alive. Participants were uncertain and anxious about any interruption of, or changes to, their current treatment regimen, stopping their current treatment and next steps.
Conclusion
Interventions are needed to support the psychological needs of people using IBP therapies. These should go beyond monitoring and managing IBP treatment‐related adverse effects and address uncertainty and psychological dependency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK.
- Newcastle University Centre for Cancer, Newcastle University, Newcastle Upon Tyne, UK.
- Northern Centre for Cancer Care, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
- Patient and Public Involvement, Newcastle Upon Tyne, UK.
- Nursing Directorate, Imperial College Healthcare NHS Trust, London, UK.
- Department of Surgery and Cancer, Imperial College London, London, UK.
Förderung
- Macmillan Cancer Support
Zitieren
APA
Lecouturier, J., Crowe, L., Brown, M. C., Greystoke, A., Bojke, A., Bojke, R., Richardson, J., Wells, M., Ezeala, E., Carter, L., Sharp, L., & Todd, A. (2025). “The Idea of Being Without It is Frightening”. Uncertainty and Psychological Dependency for Patients Using Immuno‐, Biological, or Precision Therapies: A Qualitative Study. Psycho-Oncology. https://doi.org/10.1002/pon.70318
Vancouver
Lecouturier J, Crowe L, Brown MC, Greystoke A, Bojke A, Bojke R, et al. “The Idea of Being Without It is Frightening”. Uncertainty and Psychological Dependency for Patients Using Immuno‐, Biological, or Precision Therapies: A Qualitative Study. Psycho-Oncology. 2025. doi:10.1002/pon.70318
BibTeX
@article{Lecouturier2025,
author = {Lecouturier, J and Crowe, L and Brown, M C and Greystoke, A and Bojke, A and Bojke, R and Richardson, J and Wells, M and Ezeala, E and Carter, L and Sharp, L and Todd, A},
title = {“The Idea of Being Without It is Frightening”. Uncertainty and Psychological Dependency for Patients Using Immuno‐, Biological, or Precision Therapies: A Qualitative Study},
journal = {Psycho-Oncology},
year = {2025},
doi = {10.1002/pon.70318}
}
EUVIMED